ArticleSurgery today2026
Economic outcomes of robot-assisted surgery for gastric and colorectal cancer at a general hospital: a real-world analysis of the volume-cost dilemma.
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMost economic analyses of robot-assisted surgery (RAS) have been conducted at high-volume centers. We evaluated RAS economics at a general hospital, hypothesizing a Volume-Cost Dilemma of disproportionately high per-case fixed costs at low case volumes.
methodsThis retrospective study compared robotic-assisted and laparoscopic surgery for 125 curative gastric cancer resections (Laparoscopic n=63, Robotic n=62) and 161 colorectal cancer resections (Laparoscopic n=65, Robotic n=96) performed between 2021 and 2024. Gross Surgical Profit (GSP) was defined as the surgical fee minus materials, labor (micro-costing), and maintenance costs. Break-even volume was estimated from the median marginal profit per robotic case (gastric cancer reference model).
resultsThe median GSP was significantly lower in the Robotic group for gastric (+¥468,181 vs. -¥148,835) and colorectal cancer (+¥394,959 vs. -¥190,573; both p<0.001), driven by 17.5-fold higher robotic maintenance costs (¥386,000 vs. ¥22,000/case). Low anterior resection alone showed a positive Robotic GSP (+¥69,876). Break-even required 233 robotic cases under the gastric cancer reference model, which is 1.6 times the current volume of 143.
conclusionsA structural Volume-Cost Dilemma, driven by high fixed-maintenance costs, was observed in RAS at a general hospital, proposed as an interpretive framework. Resolving this requires in-hospital cost reduction combined with centralization under the 2026 reimbursement reform, underscoring the need for volume-sensitive policy and multicenter research.
Indexed as
Identifiers
42611262What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.